Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease

Informazioni relative al progetto

ADDIA

ID dell’accordo di sovvenzione: 674474

DOI

10.3030/674474

Progetto chiuso

Data della firma CE 10 Luglio 2015

Data di avvio 1 Agosto 2015

Data di completamento 31 Luglio 2019

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 4 998 625,00

Contributo UE

€ 4 998 625,00

Coordinato da

AMONETA DIAGNOSTICS
France

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (2)

Letters and project updates to patient organisation Alzheimer Europe

AD patient organizations will be contacted to disseminate the project progress regarding AD diagnosis with the ADDIA assay to AD patients and their families, via announcements on patient organization’s websites and sending out letters.

Scientific papers prepared for peer-reviewed open access journals

Amoneta aims to raise the awareness, acceptance and support of the scientific and medical experts regarding the novel IVD assay for AD diagnosis:  Outcomes from the ADDIA project will be presented at international and national conferences.  Regular updates (in the form of abstracts, presentations, posters) regarding the progress of the project and the preliminary results will be provided to all relevant scientific organisations at European and international level.  Scientific articles of the findings of the clinical trial will be published in (open access) peer reviewed scientific and medical journals.

Pubblicazioni

Conference proceedings (2)

ADDIA Chronobiology Study and Proof-of-Performance Study to Validate Blood-Based Biomarkers for the Diagnostic of early Alzheimer’s Disease (AD)

Autori: F. Blanc, F. Giovanni, M. Marizzoni, C. Mutter, J.C. Bier, F. Sellal, J.F. Démonet, S. Boutillier, H. Firat, S. Moussaoui, R. David, A. Ivanoiu, E. Magnin, A. Gabelle, F. Pasquier, H. Gurvit, B. Dubois
Pubblicato in: 2019
Editore: Alzheimer's and Parkinson's diseases

Addia, a Multi- Center Clinical Study of Proof-of-Performance to Validate Blood-Based Biomarkers for the Diagnostic of Alzheimer’s Disease (AD): The Study Protocol.

Autori: Bruno Dubois, MD, PhD, Professor, Jean-Christophe Bier, MD, Frederic Blanc, MD, PhD, Renaud David, MD, PhD, Jean-François Démonet, MD, PhD, Hüseyin Firat, MD, PhD, Giovanni B Frisoni, Prof, PhD, MD, Audrey Gabelle, MD, PhD, Hakan I. Gurvit, MD, Adrian Ivanoiu, MD, PhD, Eloi Magnin, MD, PhD, Moira Marizzoni, PhD, Saliha Moussaoui, PhD, Florence Pasquier, MD PhD and François Sellal, MD
Pubblicato in: 2018
Editore: Alzheimer's Association International Conference

Diritti di proprietà intellettuale

Patent (7)

NON-CODING RNAS (NCRNA) FOR THE DIAGNOSIS OF COGNITIVE DISORDERS

Numero candidatura/pubblicazione: WO 2019048500
Data: 2017-09-05
Candidato/i: AMONETA DIAGNOSTICS

DETECTION OF NEURODEGENERATIVE DISEASES

Numero candidatura/pubblicazione: EP 17719325
Data: 2017-03-07
Candidato/i: AMONETA DIAGNOSTICS

DIPYRROMETHENE-BORON HYDROPHILIC FLUORESCENT COMPOUNDS

Numero candidatura/pubblicazione: EP 09805741
Data: 2009-12-18
Candidato/i: AMONETA DIAGNOSTICS

Unsaturated dibenzopyrromethene-boron borocarbons

Numero candidatura/pubblicazione: WO2006/087458 2006/087458
Data: 2005-02-15
Candidato/i: AMONETA DIAGNOSTICS

NOVEL FLUORESCENT BORON-SUBSTITUTED DIPYRROMETHENES AND USE THEREOF FOR DIAGNOSIS

Numero candidatura/pubblicazione: EP 09806180
Data: 2009-12-28
Candidato/i: AMONETA DIAGNOSTICS

UNSATURATED DIPYRROMETHENE-BORON BOROCARBONS

Numero candidatura/pubblicazione: EP 06709313
Data: 2006-02-14
Candidato/i: AMONETA DIAGNOSTICS

Biological complex specific for Alzheimer's disease detection in vitro and use thereof

Numero candidatura/pubblicazione: US20130289140 20130289140
Data: 2013-04-30
Candidato/i: AMONETA DIAGNOSTICS